Lea Maria Merz Florian Buerger Niels Ziegelasch Martin Zenker Ilse Wieland Tobias Lipek Tillmann Wallborn Nicolas Terliesner Freerk Prenzel Manuela Siekmeyer Katalin Dittrich
10.3389/fendo.2022.866831
Front Endocrinol (Lausanne)
2022 May 6;13:866831.
burosumab cutaneous-skeletal-hypophosphatemia-syndrome epidermal nevus syndrome hypophosphatemia hypophosphatemic rickets
CC BY
https://pubmed.ncbi.nlm.nih.gov/35600592/
Familial Hypophosphatemic Rickets / complications Familial Hypophosphatemic Rickets / drug therapy Hypophosphatemia / chemically induced Hypophosphatemia / drug therapy Rickets, Hypophosphatemic
Familial Hypophosphatemic Rickets / complications Familial Hypophosphatemic Rickets / drug therapy Hypophosphatemia / chemically induced Hypophosphatemia / drug therapy Rickets, Hypophosphatemic Case Reports Research Support, Non-U.S. Gov't Antibodies, Monoclonal, Humanized Child, Preschool Female Humans Syndrome Antibodies, Monoclonal, Humanized burosumab
PMC9120998
35600592
A Case Report: First Long-Term Treatment With Burosumab in a Patient With Cutaneous-Skeletal Hypophosphatemia Syndrome
2022